Metastatic Leiomyosarcoma Biomarker Protocol
Metastatic Leiomyosarcoma Biomarker Protocol
Recruiting · NCT05653388 · Registry updated 2026-06-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metastatic Leiomyosarcoma Biomarker Protocol | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, leiomyosarcoma, myomatous neoplasm, neoplasm, sarcoma | Recruiting | Not stated | 2026-06-24 | NCT05653388 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| University of Michigan Rogel Cancer Center | 63 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chris O'Brien Lifehouse | Camperdown | Australia | 46 |
| Dana- Farber | Boston | United States | 1 |
| Mayo Clinic | Rochester | United States | 22 |
| MD Anderson | Houston | United States | 56 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Ohio State University | Columbus | United States | 169 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| Sarcoma Oncology Research Center | Santa Monica | United States | 9 |
| University of Miami | Miami | United States | 327 |
| University of Michigan Cancer Center | Ann Arbor | United States | 7 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |